Who Owns IDEXX Laboratories Stock?
NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 518.00 0.00%
Ownership breakdown
- Held by institutions
- 96.70%
- Held by insiders
- 0.22%
- Institutional holders
- 1,850
- Institutions 96.7%
- Insiders 0.2%
- Public and other 3.1%
Who owns IDEXX Laboratories stock?
Institutional investors own about 96.7% of IDEXX Laboratories's shares, spread across 1,850 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.22% of IDXX.
The largest institutional holders are Blackrock Inc. (10.37%), Vanguard Capital Management LLC (6.54%) and Vanguard Portfolio Management LLC (4.95%). Together, the top 10 institutions control 41.5% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their IDXX positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IDXX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 8.17M | 10.37% | -2.3% |
| Vanguard Capital Management LLC | 5.15M | 6.54% | -0.6% |
| Vanguard Portfolio Management LLC | 3.90M | 4.95% | -0.4% |
| State Street Corporation | 3.75M | 4.76% | +2.0% |
| Invesco Ltd. | 3.61M | 4.58% | +7.8% |
| Geode Capital Management, LLC | 2.56M | 3.25% | -3.7% |
| BAMCO Inc. | 1.98M | 2.51% | +21.0% |
| Morgan Stanley | 1.36M | 1.72% | +3.0% |
| Bank Of New York Mellon Corporation | 1.19M | 1.51% | -20.7% |
| Arrowstreet Capital, Limited Partnership | 1.07M | 1.35% | +27.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IDXX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.50M | 3.18% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.04M | 2.59% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 1.71M | 2.17% |
| Invesco QQQ Trust, Series 1 | 1.70M | 2.15% |
| iShares Trust-iShares Core S&P 500 ETF | 1.05M | 1.33% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.02M | 1.30% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 966.42K | 1.23% |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 942.29K | 1.20% |
| BARON SELECT FUNDS-Baron Partners Fund | 846.30K | 1.07% |
| Amcap Fund | 732.86K | 0.93% |
Frequently asked questions
Who is the largest shareholder of IDEXX Laboratories?
Blackrock Inc. is the largest institutional shareholder of IDXX, owning 10.37% of shares outstanding (8.17M shares) as of its latest 13F filing.
What percentage of IDEXX Laboratories is owned by institutions?
Institutions own about 96.7% of IDXX shares and 96.9% of the public float.
How much of IDEXX Laboratories do insiders own?
Insiders, such as officers and directors, own about 0.22% of IDXX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.